Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqing Lou

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
NPJ Precision Oncology|February 27, 2024
Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinomaYanwei Zhang, Beibei Sun, Yinghong Yu, et al.
Frontiers in Cardiovascular Medicine|December 14, 2023
Safety and effects of a home-based Tai Chi exercise rehabilitation program in patients with chronic heart failure: study protocol for a randomized controlled trialQian Jiao, Chao Meng, Haoqiang He, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 22, 2022
Screening anlotinib responders via blood-based proteomics in non-small cell lung cancerJun Lu, Wei Zhang, Keke Yu, et al.
Frontiers in Genetics|September 24, 2021
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among <i>TP53</i>-Negative NSCLC PatientsJun Lu, Yanwei Zhang, Yuqing Lou, et al.
Clinical Lung Cancer|August 5, 2020
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled StudyQing Chang, Jianlin Xu, Huiping Qiang, et al.
Thoracic Cancer|September 2, 2022
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancerYujing Li, Yanan Wang, Wensheng Zhou, et al.
Molecular Biology Reports|April 17, 2013
β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysisHao Wang, Jielin Liu, Kuo Liu, et al.
The Journal of International Medical Research|December 31, 2019
Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patientsLiwen Xiong, Yuqing Lou, Hao Bai, et al.
Translational Lung Cancer Research|December 10, 2025
Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerationsBeibei Liu, Danni Wang, Yujing Li, et al.
Materials Today. Bio|February 24, 2026
Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identificationBeibei Liu, Huiyan Cheng, Keke Yu, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
NPJ Precision Oncology|February 27, 2024
Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinomaYanwei Zhang, Beibei Sun, Yinghong Yu, et al.
Frontiers in Cardiovascular Medicine|December 14, 2023
Safety and effects of a home-based Tai Chi exercise rehabilitation program in patients with chronic heart failure: study protocol for a randomized controlled trialQian Jiao, Chao Meng, Haoqiang He, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 22, 2022
Screening anlotinib responders via blood-based proteomics in non-small cell lung cancerJun Lu, Wei Zhang, Keke Yu, et al.
Frontiers in Genetics|September 24, 2021
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among <i>TP53</i>-Negative NSCLC PatientsJun Lu, Yanwei Zhang, Yuqing Lou, et al.
Clinical Lung Cancer|August 5, 2020
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled StudyQing Chang, Jianlin Xu, Huiping Qiang, et al.
Thoracic Cancer|September 2, 2022
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancerYujing Li, Yanan Wang, Wensheng Zhou, et al.
Molecular Biology Reports|April 17, 2013
β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysisHao Wang, Jielin Liu, Kuo Liu, et al.
The Journal of International Medical Research|December 31, 2019
Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patientsLiwen Xiong, Yuqing Lou, Hao Bai, et al.
Translational Lung Cancer Research|December 10, 2025
Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerationsBeibei Liu, Danni Wang, Yujing Li, et al.
Materials Today. Bio|February 24, 2026
Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identificationBeibei Liu, Huiyan Cheng, Keke Yu, et al.
Pageof 12